Cite
HARVARD Citation
Paggiaro, P. et al. (n.d.). S49 Dupilumab improves lung function across baseline disease characteristics in patients with evidence of type 2 inflammation at baseline: the LIBERTY ASTHMA QUEST study. Thorax. pp. A33-A34. [Online].